The Lancet breast cancer commission
Dodwell D,  Coles CE,  Earl H,  Anderson BO,  Barrios CH,  Bienz M,  Bliss JM,  Cameron DA,  Cardoso F,  Cui W,  Francis PA,  Jagsi R,  Knaul FM,  McIntosh SA,  Phillips K-A,  Radbruch L,  Thompson MK,  André F,  Abraham JE,  Bhattacharya IS,  Franzoi MA,  Drewett L,  Fulton A,  Kazmi F,  Inbah Rajah D,  Mutebi M,  Ng D,  Ng S,  Olopade OI,  Rosa WE,  Rubasingham J,  Spence D,  Stobart H,  Vargas Enciso V,  Vaz-Luis I,  et al. (2024)

Palliative radiotherapy: survival prognostic factors - single-centre retrospective cohort study.
Cooper S,  Denholm M,  Malek AS,  Rubasingham JA,  Tsang D,  et al. (2024)

Sonosensitive cavitation nuclei-a customisable platform technology for enhanced therapeutic delivery
Lyons B,  Balkaran JPR,  Dunn-Lawless D,  Lucian V,  Keller SB,  O'Reilly CS,  Hu L,  Rubasingham J,  Nair M,  Carlisle R,  Stride E,  Gray M,  Coussios C,  et al. (2023)

The Lancet Breast Cancer Commission: tackling a global health, gender, and equity challenge.
Coles CE,  Anderson BO,  Cameron D,  Cardoso F,  Horton R,  Knaul FM,  Mutebi M,  Lee N,  Lancet Breast Cancer Commission ,  et al. (2022)

Improving Waiting Times from Decision to Treat to Starting Treatment in Head and Neck Cancers: An Audit of the 17-day Pathway
Rubasingham J,  Gemmill J,  James E,  Twyman N,  Gatfield E,  Barnett G,  Benson R,  Jadon R,  et al. (2022)

The challenges of managing immunotherapy-induced type 1 diabetes mellitus presenting as diabetic ketoacidosis: a case report
Tharmakulasingam S,  Rubasingham J,  Mithra S,  Cooper S,  Malek A,  Dancey G,  Islam M,  et al. (2020)

Pulmonary sarcoidosis masquerading as metastatic cervical cancer: a pitfall in CT scans and positron emission tomography (PET).
Rubasingham J,  Marzouk S,  Madhavan K,  Sioftanos G,  Liyanage SH,  et al. (2020)

Survival outcomes after whole brain radiotherapy in non-small cell lung cancer patients with brain metastases: a single centre experience
Rubasingham J,  Malek A,  Cooper S,  Mithra S,  Dancey G,  Islam M,  et al. (2020)

Developing a nurse consultant-led immunotherapy services in a district general hospital
Muthukumar D,  Sheen L,  Rubasingham J,  Saunders E,  et al. (2019)

A case of hyperprogression of lung cancer following atezolizumab
Muthukumar D,  Saunders E,  Rubasingham J,  Nagarajah V,  et al. (2019)

A single centre experience of anti-PDL1 and anti-PD1 agents in treatment of non-small cell lung cancer (NSCLC)
Saunders E,  Rubasingham J,  Muthukumar D,  Ingle C,  et al. (2019)

Real-world Factors Predicting Complete Pathological Response to Neoadjuvant Chemotherapy in Breast Cancer
Rubasingham J,  Loo V,  et al. (2019)

Outcomes in palliative radiotherapy for Glioblastoma Multiforme: A single centre experience
Ohiozua E,  Spencer A,  Rubasingham J,  Bye M,  Kang G,  Judge T,  Levy S,  Maund I,  Sioftanos G,  et al. (2019)

Urgent radiotherapy (within 24 hours) for metastatic spinal cord compression (MSCC) – a one-year single institution experience.
Malek A,  Rubasingham J,  Cooper S,  Ohiozua E,  Ibikunle Y,  Perera D,  Sioftanos G,  et al. (2019)

Audit of 30-day mortality following palliative radiotherapy at Southend University Hospital
Denholm M,  Cooper S,  Malek A,  Rubasingham J,  Mithra S,  Tsang D,  et al. (2019)

115P Heart and pulmonary artery radiation doses in non-small cell lung cancer
Jayaprakash KT,  Rubasingham J,  Ingle CJ,  Muthukumar D,  et al. (2018)

Neoadjuvant chemotherapy outcomes in breast cancer: a single institution experience
Rubasingham J,  Loo V,  et al. (2018)

Predicting outcomes in native AV forearm radio-cephalic fistulae; the CAVeA2T2 scoring system.
Bosanquet DC,  Rubasingham J,  Imam M,  Woolgar JD,  Davies CG,  et al. (2015)